Skip to main content

Table 2 (abstract P036). See text for description

From: 39th International Symposium on Intensive Care and Emergency Medicine

Secondary Outcomes

Aspirin (n=23)

Placebo (n=25)

p-value

Length of ICU stay, days

4.1 [2.2-8.7]

4.9 [3.4-8]

0.37

ICU mortality – no (%)

0

2 (8)

0.49

Hospital mortality – no (%)

1 (4.3)

2 (8.0)

>0.99

28-day mortality – no. (%)

1 (4.3)

2 (8.0)

>0.99

Patient with transfusion in ICU – no. (%)

3 (13.0)

3 (12.0)

>0.99

Episodes of clinically identified bleeding in ICU

0

0

-

Lowest platelet count in ICU, x1000/mm3

186 [112-228]

164 [120-238]

0.88

  1. Data presented as number (percentage) and median [interquartile range]